FDA Increases Monetary Penalties For Tobacco Regulation Violations
The U.S. Food and Drug Administration (FDA) has amended the schedule for its Civil Monetary Penalties (CMP). These monetary penalties are levied against tobacco...
Tobacco 21 Bill Introduced in U.S. House of Representatives
Tobacco 21 legislation, which has been a legislative approach to combating tobacco use and nicotine addiction among America's youth in several states and local...
Cigar Advocacy Groups Claim FDA Is Infringing on Commercial Free Speech
Are increased tobacco user fees and bigger warning label requirements infringing on cigar manufacturers’ Constitutional rights? According to several cigar industry advocacy groups, the...
Warnings Galore: Understanding California’s Proposition 65
Under the U.S. Food and Drug Administration’s (FDA) final rule deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act...
Premium Cigar Manufacturers File Joint FDA Comment on Regulations
Some of the largest premium cigar manufacturers have come together to file a comment with the U.S. Food and Drug Administration on the subject...
Vapor Industry Strikes Back at FDA With Multiple Lawsuits
Just as the FDA faces various lawsuits from the premium cigar industry, the vape category is also legally challenging the controversial deeming rules as...
FDA Officially Launches “This Is Our Watch” Program for Tobacco Retailers
This month, the U.S. Food and Drug Administration (FDA) officially launched “This Is Our Watch”, a program geared toward tobacco retailers to help tackle...
FDA Issues ANPRM for Premium Cigar Regulation
The U.S. Food and Drug Administration (FDA) has published an advanced notice of proposed rule making (ANPRM) specifically for premium cigars. The ANPRM seeks...
J.C. Newman Cigar Co. Takes On FDA’s Substantial Equivalency Process
J.C. Newman Cigar Co. has been active in the fight against the U.S. Food and Drug Administration (FDA) regulation of premium cigars. The company...
Cole-Bishop Bill Reintroduced in Congress
U.S. Representatives Tom Cole (R-Oklahoma) and Cole Bishop (D-Georgia) reintroduced legislation in Congress in an effort to change the FDA predicate date under the...
